
What We’re Reading: COVID-19 Pill Data to FDA; Vaccinated Travelers to Be Allowed in US; Michigan Boosts Mental Health Clinic Funding
Merck has submitted data on its COVID-19 pill to the FDA after a successful trial; air, land, and ferry travelers will be allowed into the United States in November if they show proof of vaccination; 13 of 33 certified community behavioral health clinics in Michigan will be reimbursed by Medicaid.
Merck Requests Emergency Authorization for COVID-19 Pill Molnupiravir
Molnupiravir is a twice-daily pill developed by Merck that has been shown to reduce the risk of hospitalization and death caused by COVID-19, and it could be widely used as a treatment in the near future if approved for emergency use,
Foreign Travelers Vaccinated Against COVID-19 Allowed in US November 8
The White House has decided that foreign travelers vaccinated against COVID-19 will be allowed into the United States starting November 8,
Behavioral Health Clinics in Michigan to Receive Additional Medicaid Funding
Starting this month, 13 mental health and addiction clinics across Michigan will receive the same Medicaid funding as any other health center,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.